We are live on
!
Find out more
LIM
Lagoda Investment Management Portfolio holdings
AUM
$162M
1-Year Est. Return
49.7%
This Fund
S&P 500
This Quarter
Est. Return
+7.89%
1 Year Est. Return
+49.7%
3 Year Est. Return
+193.16%
5 Year Est. Return
+230.21%
10 Year Est. Return
+1,614.49%
AUM
$147M
AUM Growth
-$5.32M
(-3.5%)
Cap. Flow
-$13M
Cap. Flow
% of AUM
-8.88%
Top 10 Holdings %
Top 10 Hldgs %
78.06%
Holding
42
New
–
Increased
10
Reduced
15
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Transmedics
TMDX
|
+$1.63M |
| 2 |
Trupanion
TRUP
|
+$529K |
| 3 |
RXO
RXO
|
+$145K |
| 4 |
Ubiquiti
UI
|
+$102K |
| 5 |
Eaton
ETN
|
+$55.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$7.82M |
| 2 |
Natera
NTRA
|
+$1.43M |
| 3 |
Texas Pacific Land
TPL
|
+$1.31M |
| 4 |
Royalty Pharma
RPRX
|
+$1.06M |
| 5 |
Corpay
CPAY
|
+$947K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.19% |
| 2 | Energy | 21.84% |
| 3 | Industrials | 16.55% |
| 4 | Financials | 15.4% |
| 5 | Healthcare | 14.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
ExxonMobil
XOM
$657B
| $417K | 0.28% |
4,175
| – | – |
|
|
NVO
27
Novo Nordisk
NVO
$207B
| $391K | 0.27% |
3,780
| – | – |
|
|
PBT
28
Permian Basin Royalty Trust
PBT
$1.52B
| $361K | 0.25% |
25,875
-1,375
| -5% | -$24.6K |
|
|
29
Eaton
ETN
$178B
| $308K | 0.21% |
1,280
+250
| +24% | +$55.2K |
|
30
CME Group
CME
$93.2B
| $284K | 0.19% |
1,350
| – | – |
|
31
Quanta Services
PWR
$101B
| $270K | 0.18% |
1,250
+50
| +4% | +$9.24K |
|
32
Alphabet (Google) Class A
GOOGL
$4.2T
| $161K | 0.11% |
1,150
| – | – |
|
33
Franco-Nevada
FNV
$46.4B
| $134K | 0.09% |
1,212
-300
| -20% | -$36.5K |
|
34
SPDR Gold Trust
GLD
$143B
| $124K | 0.08% |
650
| – | – |
|
35
ConocoPhillips
COP
$151B
| $92.9K | 0.06% |
800
| – | – |
|
36
Rivian
RIVN
$23.7B
| $90.3K | 0.06% |
3,850
+1,650
| +75% | +$31K |
|
37
Brown-Forman Class B
BF.B
$12.9B
| $72.8K | 0.05% |
1,275
| – | – |
|
38
Phillips 66
PSX
$89.5B
| $22.6K | 0.02% |
170
| – | – |
|
39
Abbott
ABT
$190B
| $17.6K | 0.01% |
160
-180
| -53% | -$18K |
|
|
40
Royalty Pharma
RPRX
$25.7B
| – | – |
-38,930
| Closed | -$1.06M |
|
|
41
Corpay
CPAY
$26.7B
| – | – |
-3,708
| Closed | -$947K |
|
|
SGEN
42
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-36,850
| Closed | -$7.82M |
|
Similar funds
AXA
TFP
CWMGO
SWMG
GPA
CC
IVGAI
PCR
Lagoda Investment Management's Q4 2023 Portfolio in Review
As of Q4 2023, Lagoda Investment Management held 42 positions worth $147M, down 3.5% from $152M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Lagoda Investment Management withdrew a net $13M in Q4 2023, closing 3 positions and reducing 15 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $7.82M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Energy and Industrials.
Against the trend, Lagoda Investment Management added an estimated $1.63M to Transmedics.
- Lagoda Investment Management added most to Transmedics in Q4 2023, an estimated $1.63M increase.
- Lagoda Investment Management's biggest Q4 2023 reduction was Natera, cutting an estimated $1.43M.
- Lagoda Investment Management fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $7.82M.
- Lagoda Investment Management's ten largest holdings make up 78% of its $147M portfolio in Q4 2023.
- Lagoda Investment Management opened 0 new positions and closed 3 in Q4 2023.
- Lagoda Investment Management's portfolio value fell 3.5% quarter-over-quarter to $147M.
Based on Lagoda Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.